Early versus late add-on therapy in generalized myasthenia gravis: a multicenter real-world cohort study
{{output}}
Background: This study examined whether the timing of targeted add-on therapy initiation influences clinical outcomes in acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (gMG), based on the hypothesis... ...
